Phase 4 Myasthenia Gravis Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc.75 enrolled12 locationsNCT07221838
Recruiting
Phase 4
Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis
Myasthenia Gravis
UCB Biopharma SRL40 enrolled11 locationsNCT07246564
Recruiting
Phase 4
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
New Onset Generalized Myasthenia Gravis (gMG)
argenx30 enrolled18 locationsNCT06909214
Recruiting
Phase 4
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
Myasthenia Gravis, Generalized
Centre Hospitalier Universitaire de Nice50 enrolled1 locationNCT07072988
Recruiting
Phase 4
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
AChR Myasthenia GravisMyasthenia Gravis CrisisMyasthenia Gravis Exacerbations
University of Colorado, Denver20 enrolled1 locationNCT06860633